These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2474544)

  • 1. Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope.
    Swenson TL; Hesler CB; Brown ML; Quinet E; Trotta PP; Haslanger MF; Gaeta FC; Marcel YL; Milne RW; Tall AR
    J Biol Chem; 1989 Aug; 264(24):14318-26. PubMed ID: 2474544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective binding of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity.
    Wang S; Kussie P; Deng L; Tall A
    J Biol Chem; 1995 Jan; 270(2):612-8. PubMed ID: 7822286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies.
    Roy P; MacKenzie R; Hirama T; Jiang XC; Kussie P; Tall A; Rassart E; Milne R
    J Lipid Res; 1996 Jan; 37(1):22-34. PubMed ID: 8820099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein. Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody.
    Wang S; Wang X; Deng L; Rassart E; Milne RW; Tall AR
    J Biol Chem; 1993 Jan; 268(3):1955-9. PubMed ID: 7678413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity.
    Wang S; Deng L; Milne RW; Tall AR
    J Biol Chem; 1992 Sep; 267(25):17487-90. PubMed ID: 1381349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer.
    Saito K; Kobori Ki; Hashimoto H; Ito S; Manabe M; Yokoyama S
    J Lipid Res; 1999 Nov; 40(11):2013-21. PubMed ID: 10553005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiedendiol-A inhibits cholesteryl ester binding to its transfer protein.
    Wang S; Clemmons A; Chackalamannil S; Coval SJ; Sybertz E; Burrier R
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):408-12. PubMed ID: 10375797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
    Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism.
    Whitlock ME; Swenson TL; Ramakrishnan R; Leonard MT; Marcel YL; Milne RW; Tall AR
    J Clin Invest; 1989 Jul; 84(1):129-37. PubMed ID: 2738149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of anti-human cholesteryl ester transfer protein monoclonal antibodies and radioimmunoassaying of the level of cholesteryl ester transfer protein in human plasma.
    Fukasawa M; Arai H; Inoue K
    J Biochem; 1992 Jun; 111(6):696-8. PubMed ID: 1500412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids.
    Swenson TL; Brocia RW; Tall AR
    J Biol Chem; 1988 Apr; 263(11):5150-7. PubMed ID: 2833496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma.
    Hesler CB; Tall AR; Swenson TL; Weech PK; Marcel YL; Milne RW
    J Biol Chem; 1988 Apr; 263(11):5020-3. PubMed ID: 3281933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereospecific inhibition of CETP by chiral N,N-disubstituted trifluoro-3-amino-2-propanols.
    Connolly DT; Witherbee BJ; Melton MA; Durley RC; Grapperhaus ML; McKinnis BR; Vernier WF; Babler MA; Shieh JJ; Smith ME; Sikorski JA
    Biochemistry; 2000 Nov; 39(45):13870-9. PubMed ID: 11076528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue.
    Benoist F; Lau P; McDonnell M; Doelle H; Milne R; McPherson R
    J Biol Chem; 1997 Sep; 272(38):23572-7. PubMed ID: 9295295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential role of a free sulfhydryl group in blocking the cholesteryl site of cholesteryl ester transfer protein (CETP).
    Epps DE; Vosters AF
    Chem Phys Lipids; 2002 Feb; 114(2):113-22. PubMed ID: 11934392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
    Serdyuk AP; Morton RE
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.
    Morton RE; Izem L
    J Lipid Res; 2015 Mar; 56(3):612-619. PubMed ID: 25616437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of CETP inhibitory peptide and lipoprotein substrates in cholesteryl ester transfer assay: relationship between association properties and inhibitory activities.
    Cho KH; Lee JY; Choi MS; Bok SH; Park YB
    Lipids; 2002 Jul; 37(7):641-6. PubMed ID: 12216834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody.
    Sugano M; Sawada S; Tsuchida K; Makino N; Kamada M
    J Lipid Res; 2000 Jan; 41(1):126-33. PubMed ID: 10627510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cholesteryl ester transfer activity in adipose tissue.
    Shen GX; Zhang JY; Blanchard R; Zhang HF; Hayden M; McPherson R; Angel A
    Int J Obes Relat Metab Disord; 1996 Mar; 20 Suppl 3():S114-20. PubMed ID: 8680471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.